A safety and efficacy study of autologous bone marrow cell transplantation for cirrhosis of liver caused by lifestyle related disease - ABMi therapy for liver cirrhosis(lifestyle related disease )

Heart life hospital0 个研究点目标入组 10 人开始时间: 2014年10月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Hepatocellular carcinoma (HCC), except for cases having been treated completely without history of recurrence 2) Maligi1ant tumor other than HCC 3) Total bilirubin under 3mg/dL 4) Hemoglobin under 8g/dl or Platelets under 50000/ul at the registration 5) Esophageal or gastric varices with a risk of bursting, except for cases only with cured history of such conditions 6) Renal dysfunction with 2mg/dl or higher serum creatinine 7) Less than six months after abstaining from alcoholic in alcoholic cirrhosis. 8) Cases that cannot obtain the informed consent to autologous blood transfusion 9) Pregnancy 10)Performance Status 3 or 4 11) Not fit for general anesthesia 12) Other conditions that doctor considered not suitable for this study

发起方

Heart life hospital